Extend screening beyond reports
Turn tests and health checks into clear priorities and follow-up.
Health signals to action
Health data into actionable intelligence
LADRTM turns screening, diagnostic and device data into personalised action pathways, follow-up and programme intelligence.
What LADRTM does
Everyday health data made more useful.
LADRTM adds validated intelligence, personalised next steps and programme visibility to services that already collect health data.
Add intelligence to test results
Give device and diagnostic data context, guidance and continuity.
Structure action pathways
Connect clinical insight to referral, follow-up and care.
Run measurable programmes
Track participation, actions and outcomes across populations.
How LADRTM works
From health signals to measurable action
A clear pathway from health data to priorities, next steps and programme insight.
Capture health signals
Bring together screening, diagnostic, device and lifestyle data.
Identify priorities
Validated intelligence shows what matters and why.
Guide the next step
Personalised actions connect people to follow-up, services or care.
Measure progress
Partners track completion, engagement and outcomes.
Choose your pathway
One intelligence layer.
Choose the route that matches how your organisation collects health data and supports action.
Screening & labsDevices & monitoringClinics & care teamsPopulation programmesHospitals & TelemedicineCorporates & Insurances
Get started
Design your first action pathway.
Start with the health signal, audience and outcome that matter most.
Evidence
Evidence behind the intelligence
Validated science, tested usability and implementation experience.
Foundation
From research lineage to health action
A healthspan intelligence layer built on two decades of research.
Stroke RiskometerTM lineage
Risk awareness, public communication and international stroke research provide the scientific starting point.
PreventS-MDTM foundation
Clinician-facing workflows, personalised outputs and usability work support routine use.
NCMA expansion
NCMA broadens the intelligence layer across shared lifestyle and cardiometabolic risks.
Implementation pathways
Configured for labs, clinics, workplaces, public programmes and research.
Evidence base
Decades of applied health research
Global Impact
0+
Publications
0+
Countries
0+
Languages
0+
Researchers
Evidence types
Evidence, clearly labelled
Scientific validity, usability and implementation answer different questions.
Usability and feasibility
PreventS-MDTM web app evidence
Evidence on healthcare-professional and at-risk user experience.
View PubMedScientific validity
Primary stroke and CVD prevention
Open-access discussion of digital solutions for primary stroke and cardiovascular disease prevention.
View articleScientific recognition
WHO innovation challenge
Recognition context for Stroke RiskometerTM and PreventS-MDTM within a health innovation programme.
View sourceScientific lineage
World Stroke Organization context
Public stroke prevention and risk-awareness context connected to Stroke RiskometerTM communication.
View sourceImplementation evidence
PROMOTE-style trials
Implementation studies can help test how digital prevention pathways work in real settings.
Discuss research useCommercial pathway
Device and platform integration
These pathways can support partner models where risk profiling and prevention reports sit beside devices or services.
Partner routesEvidence lineage
From stroke science to healthspan intelligence
Validated risk intelligence supports priorities, action pathways and programme insight.
Stroke RiskometerTM
Public-facing risk awareness and communication established the research foundation.
PreventS-MDTM
Clinician-facing workflows moved the science toward guided service delivery.
NCD risk intelligence
The model broadens across shared stroke, cardiovascular, diabetes and metabolic risks.
Partner-specific packages
Diagnostic labs, employers, insurers, public programmes and research teams can deploy profile packages around their own pathway.
Use cases
Benefits of LADRTM
Illustrative pathways for screening, employers and community health.
Partner routes
Employers
Insurers
Diagnostic labs
Device partners
Partnerships
Nutraceuticals
Trusts
Public health
Research teams
Screening & labs
Diagnostic lab pathway
Problem: Test results often end the customer journey.
Workflow: Combine lab values, vitals and participant inputs into a personalised action pathway.
Partner value: Clear priorities, clinician view, referral prompts and follow-up.
Discuss lab model
Population programmes
Community screening and outreach
Problem: Screening can identify risk without consistent follow-through.
Workflow: Standardise intake, priorities, referral flags and programme reporting.
Partner value: Participant guidance, local referral pathways and implementation insight.
Discuss outreach model
Employers
Employee health pathway
Problem: One-off health checks provide little continuity or programme visibility.
Workflow: Connect screening, personalised guidance, clinical review and aggregate analytics.
Partner value: Structured follow-up with measurable participation and action.
Discuss employer modelValidated foundation
Built on two decades of applied health research
Scientific validity supports every pathway; deployment evidence is shown separately.
Global reach
Local pathways for global problems
Regional configurations support work across Asia Pacific, India, New Zealand, the UK and Brazil.
Research & clinical partnerships
Trusted by researchers, clinicians and health organisations worldwide
Localisation
Global science, Local pathways
Every deployment needs more than translated text. It needs local thresholds, referral expectations, service roles, patient communication and governance planning.
Language
Participant-facing content can be shaped for the community and literacy level.
Care pathways
Outputs should match local clinical review, referral and follow-up options.
Governance
Data handling, consent, hosting and reporting should follow local requirements.
Partner model
Each region can start with labs, employers, clinics, schools, public programmes or research deployments.
Recognition and associations
Global research and recognition
World Health OrganizationWHO innovation award
AUT Ventures Spin out
American Heart AssociationAHA journal publication
NZTE growth focus
Prime Minister's Science Prize
Indian Council of Medical ResearchIndia research pathway
NHS UK research pathway
European Stroke Organisation supported
Design your first action pathway.
Choose a partner route or start a pilot discussion with LADRTM.
Partner routes
Choose your route
Start with how your organisation collects health data and supports action.
Screening & labs
Extend tests and health checks into personalised action and follow-up.
Devices & monitoring
Add context, guidance and continuity around health measurements.
Clinics & care teams
Structure priorities, referrals and follow-up within care workflows.
Population programmes
Support employers, insurers, trusts and public-health teams at scale.
Product selector
Ask the team to match your setting to the right cardiometabolic, cardiovascular, cognitive-health or population pathway.
Contact form
About
Longevity Architecture & Decision Roadmap
LADRTM is a healthspan intelligence layer connecting health signals, personalised action, follow-up and programme insight.
Company story
From research intelligence to operational health pathways
LADRTM turns validated research and clinical tools into deployable partner pathways.
Mission
Help people and organisations act earlier by turning complex health inputs into clear priorities and supported next steps.
Platform role
Use validated risk intelligence to identify priorities, guide next steps and measure follow-through.
Evidence posture
Use careful, evidence-informed wording and make formal institutional relationships explicit only when they are confirmed.
Product portfolio
Five validated profiles. One intelligence layer.
Each profile combines validated intake, prioritisation, personalised guidance and follow-up.
NCD & Cardiovascular Risk
Non-communicable disease profile covering cardiovascular, metabolic and lifestyle risks with clinical scoring and referral logic.
Stroke & Cardiovascular Risk
Validated stroke and cardiovascular risk intelligence, drawing on the Stroke RiskometerTM base.
Diabetes & Pre-diabetes Risk
Population-validated diabetes and metabolic risk screening with actionable lifestyle and clinical intervention recommendations.
Corporate & Employee Health
Workplace health intelligence for HR and occupational health teams, with individual reports and aggregate dashboards.
District NCD Dashboard
Public health reporting tool for local government and health ministry teams - population-level NCD prevalence, risk stratification and programme outcome tracking.
Resources
Implementation resources for health partners
Guides and references for moving from first conversation to a live pathway.
Evidence base
Published research, award records and implementation studies behind the PreventS-MDTM and NISAN/AUT prevention lineage.
View evidenceGlobal deployment
Country profiles, local partner models and governance frameworks for prevention deployments across Asia, Europe and the Pacific.
See global reachPartner pathway planning
Choose the right model for labs, employers, public programmes or research.
Start planningPlatform overview
Technical and clinical overview of LADRTM intelligence, follow-up and programme analytics.
Request overviewPrivacy
Privacy approach
LADRTM pathways may involve health, lifestyle and programme data. Privacy settings should be defined for each deployment country, partner role and hosting model.
Data handling principles
Collect only what is needed for the agreed pathway, separate participant and programme outputs where appropriate, and align storage, access and reporting with local law and partner governance.
Terms
Terms of use
This website is intended for partnership, product and implementation discussions. Final clinical, commercial and regulatory responsibilities should be documented in formal agreements.
Use of information
Site content is for general information and partnership discussion. Clinical use, product claims, regulatory status and partner responsibilities should be defined in formal agreements.
Contact
Design a pathway, partnership or pilot
Talk to LADRTM about data, audience and the outcome you want to connect.